This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under CFDA Program 93.859 Biomedical Research and Research Training, provides $534,450 in funding to the University of Pennsylvania to support a 5-year Predoctoral Training Program in Pharmacology. The program aims to prepare graduate students for productive careers in disciplines requiring fundamental knowledge of quantitative and systems pharmacology. Key program elements include coursework in...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) provides $426,360 in funding to Case Western Reserve University (CWRU) from July 1, 2025 to June 30, 2030. The purpose of this award is to support the Molecular Pharmacology Training Program (MPTP), an interdisciplinary PhD program focused on developing innovative scientists with strong foundations in pharmacological principles and...
The National Institute of General Medical Sciences (NIGMS) awarded a $268,725 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to Purdue University. The grant, titled "Purdue Drug Discovery Training Program," aims to provide predoctoral students with cross-disciplinary training at the chemical-biology interface pertaining to drug discovery. The program's objective is to equip trainees with a comprehensive skill set, exposure to the drug...
The National Institute of General Medical Sciences (NIGMS) has awarded a Project Grant (CFDA 93.859 - Biomedical Research and Research Training) totaling $331,270 to the Icahn School of Medicine at Mount Sinai (ISMMS) to support the Integrated Training in Pharmacological Sciences Program (ITPSP). The award, effective July 15, 2025 through June 30, 2030, aims to develop highly skilled biomedical scientists who will advance drug discovery through rigorous and ethical research, leveraging...
The National Institute of General Medical Sciences (NIGMS) awarded a $103,158 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the Regents of the University of Minnesota, doing business as the Office of Sponsored Projects Administration. The grant will fund the Molecular Pharmacology and Therapeutics (MPAT) graduate program at the University of Minnesota over a 5-year period from July 2025 to June 2030. The key objectives of this grant are to transform...
The National Institute of General Medical Sciences (NIGMS) awarded a $170,400 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the Board of Regents of the Nevada System of Higher Education, operating through the University of Nevada, Reno (UNR). This 5-year grant, effective August 1, 2025, will support a predoctoral training program in interdisciplinary basic biomedical sciences. Key elements of the program include implementing new interdisciplinary...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) provides $693,422 to the University of Colorado-Denver from September 1, 2024 to August 31, 2029. The funding will support multidisciplinary research to pursue a fundamental mechanistic understanding of essential membrane transporters, which are critical for cellular function but generally understudied compared to other membrane proteins. The...
The National Institute of General Medical Sciences (NIGMS) awarded a Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the Trustees of Boston University, doing business as Boston University Medical Campus. The $233,180 grant, awarded on July 1, 2025, will fund 4 MD/PhD students per year over a 5-year period ending on June 30, 2030. The goal of the project is to recruit, train, and inspire students to become clinician-scientists who can use both their...
The U.S. National Institute of General Medical Sciences (NIGMS) awarded a $213,563.00 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to The Regents of the University of Colorado, effective September 5, 2024 through August 31, 2026. The grant funds research to develop a new class of "shape-shifting" cyclic peptides that can rapidly assume diverse structural isomers, allowing them to interact with multiple biological targets. The project aims to create a...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) provides $280,122 to the University of Maryland Baltimore County (UMBC) for the period of Jul 1, 2025 to Jun 30, 2030. The grant supports the UMBC-UMB CBI program, which aims to train Ph.D.-level scientists across chemistry and biology disciplines to address 21st century biomedical challenges. Key program components include...
The University of Colorado Anschutz Medical Campus has been awarded a $340,192 Project Grant under the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859). The 5-year grant, effective July 11, 2025 through June 30, 2030, will provide funding for the university's Pharmacology and Molecular Medicine Training Program (PHARMM) to support 8 predoctoral students annually. The program aims to provide a highly interactive, multidisciplinary training environment for students to obtain a broad, integrative perspective on pharmacology and fundamental scientific knowledge. Key program elements include a comprehensive didactic curriculum, laboratory rotations, student presentations, and access to diverse thesis research labs. The grant will enable the PHARMM program to continue developing the next generation of astute, multidisciplinary pharmacology researchers capable of effectively planning and communicating across a spectrum of scientific disciplines and technologies.